アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate 60 mg

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

remedyrepack inc. - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate 60 mg

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

unit dose services - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate 60 mg

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - isosorbide mononitrate, quantity: 60 mg - tablet, modified release - excipient ingredients: hypromellose; carnauba wax; stearic acid; lactose monohydrate; magnesium stearate; purified talc; titanium dioxide; iron oxide yellow; macrogol 4000; colloidal anhydrous silica - prophylactic treatment of angina pectoris. isosorbide-as 60mg sustained release tablets are not recommended for the management of acute attacks of angina pectoris.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - isosorbide mononitrate, quantity: 60 mg - tablet, modified release - excipient ingredients: hypromellose; carnauba wax; stearic acid; lactose monohydrate; magnesium stearate; purified talc; titanium dioxide; iron oxide yellow; macrogol 4000; colloidal anhydrous silica - prophylactic treatment of angina pectoris. isosorbide-as 60mg sustained release tablets are not recommended for the management of acute attacks of angina pectoris.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - isosorbide mononitrate, quantity: 60 mg - tablet, modified release - excipient ingredients: hypromellose; carnauba wax; stearic acid; lactose monohydrate; magnesium stearate; purified talc; titanium dioxide; iron oxide yellow; macrogol 4000; colloidal anhydrous silica - prophylactic treatment of angina pectoris. isosorbide-ga 60mg sustained release tablets are not recommended for the management of acute attacks of angina pectoris.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - isosorbide mononitrate, quantity: 60 mg - tablet, modified release - excipient ingredients: hypromellose; carnauba wax; stearic acid; lactose monohydrate; magnesium stearate; purified talc; titanium dioxide; iron oxide yellow; macrogol 4000; colloidal anhydrous silica - prophylactic treatment of angina pectoris. isosorbide-ga 60mg sustained release tablets are not recommended for the management of acute attacks of angina pectoris.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

direct rx - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate extended-release tablets are indicated for the prevention of angina pectoris due to coronary artery disease. the onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. isosorbide mononitrate extended-release tablets are contraindicated in patients who have shown hypersensitivity or idiosyncratic reactions to other nitrates or nitrites.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

lannett company, inc. - isosorbide mononitrate (unii: lx1oh63030) (isosorbide mononitrate - unii:lx1oh63030) - isosorbide mononitrate 10 mg - monoket® is indicated for the prevention and treatment of angina pectoris due to coronary artery disease. the onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode. isosorbide mononitrate is contraindicated in patients who are allergic to it. do not use monoket® in patients who are taking certain drugs for erectile dysfunction (phosphodiesterase inhibitors), such as sildenafil, tadalafil, or vardenafil.  concomitant use can cause severe hypotension, syncope, or myocardial ischemia. do not use monoket® in patients who are taking the soluble guanylate cyclase stimulator riociguat.  concomitant use can cause hypotension.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - isosorbide mononitrate, quantity: 60 mg - tablet, modified release - excipient ingredients: hypromellose; carnauba wax; stearic acid; lactose monohydrate; magnesium stearate; purified talc; titanium dioxide; iron oxide yellow; macrogol 4000; colloidal anhydrous silica - prophylactic treatment of angina pectoris. isosorbide ascent 60mg sustained release tablets are not recommended for the management of acute attacks of angina pectoris.